ScripSanofi R&D chief Houman Ashrafian is very sympathetic to the plight of cash-strapped biotechs but has implored companies not to skimp financially on the design and development of their clinical pr
ScripPureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21
ScripAfter a six-month search to find a permanent replacement for research chief John Reed, Sanofi has dipped into the venture capital sector and appointed Houman Ashrafian as its new head of R&D, effect
In VivoAs 2022 drew to a close, US President Joe Biden quietly signed a law that rewarded countless researchers and animal-rights activists with a long-sought goal – ending a decades-old requirement that all